PTPI Petros Pharmaceuticals
- 0.3785
- +0.0142+3.89%
- 0.3790
- +0.0005+0.13%
Petros Pharmaceuticals News
Petros Pharmaceuticals | 10-Q: Q2 2024 Earnings Report
Petros Pharmaceuticals | 10-K/A: Annual report (Amendment)
Petros Pharmaceuticals | EFFECT: Others
Petros Pharmaceuticals | CORRESP: CORRESP
Petros Pharmaceuticals | 10-Q: Q1 2024 Earnings Report
Petros Pharmaceuticals | UPLOAD: Others
Petros Pharmaceuticals | S-3: Registration statement for specified transactions by certain issuers
Petros Pharmaceuticals | 10-K: FY2023 Annual Report
Petros Pharmaceuticals | 8-K: Current report
Petros Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Ayrton Capital LLC(9.9%),Alto Opportunity Master Fund, SPC – Segregated Master Portfolio B(9.9%)
Petros Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Mitchell P. Kopin(6.6%),Daniel B. Asher(6.6%), etc.
Petros Pharmaceuticals | 8-K: Current report
Petros Pharmaceuticals | 8-K: Current report
Petros Pharmaceuticals | 8-K: Current report
Petros Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Bernstein Bruce
Petros Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Boctor Fady
Petros Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director WALKER WAYNE REMELL
Petros Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Arnold Mitchell
Petros Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Silverman Joshua
Petros Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Bradley Greg
Analysis
Price Target
No Data
No Data